Newsletter

145020 - Hugel, Inc.

145020 Summary
Biopharma
Stock Price & Overview
₩244,000 +3,500 (+1.46%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩244,000  ≈ US$174  ·  Market cap ₩3.1tn (≈ $2.2bn)
Home › 145020 › Filings

Proxy solicitation reference document

DART
Hugel, Inc.
Filed Aug 6, 2026 KST · Filing · receipt 20260806000471

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 의결권대리행사권유참고서류

145020

Price
₩244,000
Change
+1.46%
Market cap
₩3.1tn
Prev. close
₩240,500
145020 SummaryCompare to Peers

More 145020 filings

Large business group status disclosure — quarterly, individual company

08/31/26

Results of an extraordinary general meeting

08/24/26

Insider / Major Shareholder Holdings Report

08/21/26

Appointment, dismissal or early departure of an independent director

08/21/26

Results of an extraordinary general meeting

08/21/26

Half-Year Report

08/14/26